3887 results for «500»

Filter By

3887 results

How to build a tricuspid programme?

20 May 2025 – From EuroPCR 2025

Learn how to build a successful tricuspid valve programme with a focus on patient screening protocols, heart team roles, and post-procedural management. Gain expert perspectives on organizational requirements, referral optimization, multidisciplinary collaboration, and quality assessment for tricuspid interventions.

How to build a tricuspid programme?

Broadening OPTIONs for LAA closure: innovations and outcomes

20 May 2025 – From EuroPCR 2025

Explore the latest insights into LAA closure from EuroPCR 2025. This session highlights results from the OPTION trial—the largest RCT comparing LAAC (with Watchman FLX) to DOAC therapy in AF patients undergoing ablation. The findings? Comparable stroke prevention at 3 years, with a 56 % reduction...

Broadening OPTIONs for LAA closure: innovations and outcomes

Cardiogenic shock and high-risk interventions with percutaneous mechanical circulatory support: new evidence and insights

20 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session offers a comprehensive update on cardiogenic shock and high-risk PCI, featuring expert analysis of the DanGer-SHOCK and ECLS-SHOCK trials, new insights one year after DanGer-SHOCK, and practical considerations for managing PCI in patients with severely reduced LVEF. Expect to gain a deeper...

Cardiogenic shock and high-risk interventions with percutaneous mechanical circulatory support: new evidence and insights

Challenging scenarios in patient with multivessel disease

20 May 2025 – From EuroPCR 2025

Explore challenging clinical scenarios in patients with multivessel coronary artery disease. This session presents complex cases such as coronary aneurysms, failed bypass grafts, limitations of intravascular lithotripsy, and rare pathologies like Takayasu’s arteritis, highlighting decision-making and advanced intervention strategies.

Challenging scenarios in patient with multivessel disease

Challenges and solutions in an expanding TAVI world

20 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session addresses key challenges and emerging solutions in today’s rapidly evolving TAVI landscape. It presents the latest evidence on valve replacement in low-risk patients with aortic stenosis, alongside strategies for navigating the complexities of lifetime management in TAVI candidates. The programme features a...

Challenges and solutions in an expanding TAVI world

PCR's Got Talent Round 1 - Session 1

20 May 2025 – From EuroPCR 2025

Experience a diverse range of cutting-edge interventional cardiology topics in PCR's Got Talent Round 1. This session features presentations on PFO closure outcomes, plaque morphology, vascular injury treatments, microvascular disease assessment, TAVI-related coronary obstruction prediction, novel FFR surrogates, and more.

PCR's Got Talent Round 1 - Session 1

China experience in TAVI evolution

22 May 2025 – From EuroPCR 2025

This session highlights key innovations and recent research from China in the field of transcatheter aortic valve implantation (TAVI). Leading cardiovascular specialist present new data on pacing strategies, comparing left bundle branch area pacing with traditional right ventricular pacing in TAVI patients. They also explore the use...

China experience in TAVI evolution

Clinical implications of TAVI and cerebral embolic protection - Current challenges and future considerations

21 May 2025 – From EuroPCR 2025

Cerebral embolic protection (CEP) remains a key consideration in modern TAVI procedures, as stroke continues to be one of the most serious complications. This EuroPCR 2025 session takes a close look at the latest data on CEP use in clinical practice, weighing where it fits best...

Clinical implications of TAVI and cerebral embolic protection - Current challenges and future considerations

Tailoring transcatheter mitral therapies: a new era

20 May 2025 – From EuroPCR 2025

This session focuses on the evolving landscape of transcatheter mitral valve therapies. Learn about strategic programme development, patient phenotyping to guide device selection and repair versus replacement decisions, and the latest innovations and approvals in transcatheter mitral valve replacement.

Tailoring transcatheter mitral therapies: a new era

Complex calcified lesions: combination of intravascular imaging and orbital atherectomy for optimal outcomes

20 May 2025 – From EuroPCR 2025

In this EuroPCR 2025 session on complex calcified coronary lesions, follow a step-by-step analysis of a recorded case structured in three key phases: lesion assessment with OCT, PCI using orbital atherectomy, and post-PCI optimisation with follow-up OCT imaging. Gain valuable insights into managing severely calcified lesions,...

Complex calcified lesions: combination of intravascular imaging and orbital atherectomy for optimal outcomes

Managing complex STEMI patients in diverse healthcare systems - Adapting best practices to local realities

20 May 2025 – From EuroPCR 2025

Addressing the complexities of STEMI management across diverse healthcare systems, this session highlights challenges and adaptive strategies tailored to geographic and resource-specific realities. Learn from regional experts on thrombus burden, late presentations, cardiogenic shock, and multivessel disease management.

Managing complex STEMI patients in diverse healthcare systems - Adapting best practices to local realities

Enhancing clipping solutions for durable long-term patient outcomes

21 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session delves into the evolving strategies for mitral and tricuspid TEER, backed by fresh data and real-world insights. Review the latest evidence from the TRILUMINATE Pivotal and bRIGHT studies, and see how TR phenotypes can guide patient selection for more durable outcomes. Discover...

Enhancing clipping solutions for durable long-term patient outcomes

Evolving bifurcation treatment practices: drug-coated balloons, angio-based FFR, and side branch optimisation

20 May 2025 – From EuroPCR 2025

Explore how bifurcation treatment is evolving with the integration of drug-coated balloons, angio-based FFR, and advanced side branch optimisation. This EuroPCR 2025 session highlights why DCB is gaining traction for bifurcation lesions and introduces the upcoming EBC-DCB trial comparing a stepwise DCB strategy to provisional DES...

Evolving bifurcation treatment practices: drug-coated balloons, angio-based FFR, and side branch optimisation

From imaging to intervention: cutting-edge solutions for calcified coronary stenoses management

20 May 2025 – From EuroPCR 2025

Watch this EuroPCR 2025 session on managing calcified coronary stenoses, featuring a recorded live case, two focused lectures, and expert faculty insights. Learn why intravascular ultrasound (IVUS) is essential for assessing lesion severity and morphology, discover how selecting the right calcium modification tools drives procedural success...

From imaging to intervention: cutting-edge solutions for calcified coronary stenoses management

TAVI in patients with a small annulus

20 May 2025 – From EuroPCR 2025

Address the unique challenges of transcatheter aortic valve implantation (TAVI) in patients with small aortic annuli. This session discusses comparative outcomes of balloon-expandable versus self-expandable valves, size prediction methodologies, and management of paravalvular regurgitation in low-flow, low-gradient aortic stenosis cases.

TAVI in patients with a small annulus

New evidence for treatment of calcified coronary artery disease

20 May 2025 – From EuroPCR 2025

Explore the latest randomized trials and studies advancing the treatment of calcified coronary artery disease. This session covers cutting balloon use, lithotripsy versus conventional preparation, and one-year outcomes comparing rotational atherectomy, lithotripsy, and laser. Also highlighted is the EMPOWER CAD study focusing on women treated with...

New evidence for treatment of calcified coronary artery disease

Degeneration of TAVI valves: a new target for innovations

19 May 2025 – From EuroPCR 2025

Discover the latest innovations targeting degeneration of TAVI valves, including expert presentations and cutting-edge technologies like The Splitter, an enabler for transcatheter aortic valve-in-valve implantation.

Degeneration of TAVI valves: a new target for innovations

How to deal with secondary mitral regurgitation in 2025?

20 May 2025 – From EuroPCR 2025

Delve into the evolving management of secondary mitral regurgitation, and the critical role of the Heart Team. This session replay presents the latest clinical trials, treatment guidelines, and a case-based discussion covering medical and interventional strategies, heart failure optimization, frailty assessment, and advanced imaging techniques.

How to deal with secondary mitral regurgitation in 2025?

The Jon DeHaan Foundation Award competition

19 May 2025 – From EuroPCR 2025

Witness innovation in action at the Jon DeHaan Foundation Award competition featuring groundbreaking technologies like synchronized diaphragmatic stimulation for heart failure and novel devices for aortic bioprosthesis and interatrial shunting.

The Jon DeHaan Foundation Award competition

Intracoronary value for PCI optimisation

20 May 2025 – From EuroPCR 2025

Optimize your PCI strategies with intracoronary insights in this session highlighting plaque stabilization, coronary stent optimization under pressure, and the critical role of intravascular imaging beyond angiography. Learn management approaches for traumatic coronary artery dissection and explore diagnosis of delayed stent fracture using enhanced stent visualization...

Intracoronary value for PCI optimisation
Didn’t find what you were looking for?